The modulation of the RAS toward a favorable balance between AngII and Ang(1-7) is increasingly considered a promising therapeutic strategy to reduce neuroinflammation and mitigate neuronal damage in neurodegenerative diseases [3]. The gene discussed is AGT; the disease is neurodegenerative disease.